chr4-139889992-T-C
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_018717.5(MAML3):āc.1444A>Gā(p.Met482Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000267 in 1,611,930 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_018717.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MAML3 | NM_018717.5 | c.1444A>G | p.Met482Val | missense_variant | 2/5 | ENST00000509479.6 | NP_061187.3 | |
MAML3 | XM_047415929.1 | c.1444A>G | p.Met482Val | missense_variant | 2/5 | XP_047271885.1 | ||
MAML3 | XM_047415930.1 | c.1444A>G | p.Met482Val | missense_variant | 2/3 | XP_047271886.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MAML3 | ENST00000509479.6 | c.1444A>G | p.Met482Val | missense_variant | 2/5 | 1 | NM_018717.5 | ENSP00000421180 | P1 | |
MAML3 | ENST00000502696.1 | c.111-159325A>G | intron_variant | 2 | ENSP00000422783 |
Frequencies
GnomAD3 genomes AF: 0.000131 AC: 20AN: 152116Hom.: 1 Cov.: 32
GnomAD3 exomes AF: 0.0000164 AC: 4AN: 243876Hom.: 0 AF XY: 0.0000226 AC XY: 3AN XY: 132452
GnomAD4 exome AF: 0.0000158 AC: 23AN: 1459696Hom.: 0 Cov.: 35 AF XY: 0.0000165 AC XY: 12AN XY: 726074
GnomAD4 genome AF: 0.000131 AC: 20AN: 152234Hom.: 1 Cov.: 32 AF XY: 0.000175 AC XY: 13AN XY: 74426
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 03, 2024 | The c.1444A>G (p.M482V) alteration is located in exon 2 (coding exon 2) of the MAML3 gene. This alteration results from a A to G substitution at nucleotide position 1444, causing the methionine (M) at amino acid position 482 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at